RECOMBIVAX HB (WITH PRESERVATIVE) DIN 00749486
Status: Cancelled Post Market
Holder: MERCK CANADA INC
Health Canada record
| Active ingredient(s) | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 10 MCG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | J07BC01 HEPATITIS B, PURIFIED ANTIGEN |
| Original market date | 31-Dec-1987 |
| Current status date | 08-Mar-2010 |
| Source | Health Canada DPD |
Establishment licence of the holder
Merck Canada Inc — licence 101380, currently licensed, last inspection rating C (2023-07-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing HEPATITIS B SURFACE ANTIGEN (RECOMBINANT)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02487039 | ENGERIX-B | GLAXOSMITHKLINE INC | Suspension | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 20 MCG | Marketed |
| 02487020 | ENGERIX-B | GLAXOSMITHKLINE INC | Suspension | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 10 MCG | Marketed |
| 02533286 | PREHEVBRIO | VBI VACCINES INC. | Suspension | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 10 MCG | Approved |
| 02561476 | RECOMBIVAX HB | MERCK CANADA INC | Solution | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 5 MCG | Marketed |
| 02245977 | RECOMBIVAX HB | MERCK CANADA INC | Suspension | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 40 MCG | Marketed |
| 02561484 | RECOMBIVAX HB | MERCK CANADA INC | Solution | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 10 MCG | Marketed |
| 02237548 | TWINRIX JUNIOR | GLAXOSMITHKLINE INC | Suspension | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 10 MCG; HEPATITIS A VIRUS, INACTIVATED 360 UNIT | Marketed |
| 02296454 | ENGERIX-B | GLAXOSMITHKLINE INC | Suspension | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 10 MCG | Cancelled Post Market |
| 01919431 | ENGERIX-B | GLAXOSMITHKLINE INC | Suspension | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 20 MCG | Cancelled Post Market |
| 02243676 | RECOMBIVAX HB | MERCK CANADA INC | Suspension | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 10 MCG | Cancelled Post Market |
| 01934023 | RECOMBIVAX HB (ADULT DIALYSIS WITH PRESERVATIVE) | MERCK CANADA INC | Solution | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 40 MCG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 7383 | 2005-09-16 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 1210 | 2000-06-12 | New Drug Submission (NDS) |